Twist Bioscience Corporation (TWST) Tops Q1 EPS by 10c

Twist Bioscience Corporation (NASDAQ: TWST) reported Q1 EPS of ($0.53), $0.10 better than the analyst estimate of ($0.63). Revenue for the quarter came in at $88.72 million versus the consensus estimate of $86.95 million.

For earnings history and earnings-related data on Twist Bioscience Corporation (TWST) click here.

You May Also Be Interested In

• UBS Upgrades Feng Tay Enterprises (9910:TT) to Buy
• JPMorgan Starts Bytes Technology Group PLC (BYIT:LN) at Underweight
• RBC Capital Downgrades AGF Management Ltd. (AGF/B:CN) (AGFMF) to Sector Perform